NASDAQ
CLPT

Clearpoint Neuro Inc

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
LIFE SCIENCES

Prices are adjusted according to historical splits.

Clearpoint Neuro Inc Stock Price

Vitals

Today's Low:
$9.5900
Today's High:
$10.0170
Open Price:
$9.9000
52W Low:
$7
52W High:
$19.5
Prev. Close:
$9.8800
Volume:
108404

Company Statistics

Market Cap.:
$0.237 billion
Book Value:
1.749
Revenue TTM:
$0.019 billion
Operating Margin TTM:
-83.1%
Gross Profit TTM:
$0.011 billion
Gross Profit TTM:
$0.011 billion
Profit Margin:
-85.9%
Return on Assets TTM:
-14.9%
Return on Equity TTM:
-36.1%

Company Profile

Clearpoint Neuro Inc had its IPO on 2020-02-12 under the ticker symbol CLPT.

The company operates in the LIFE SCIENCES sector and SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry. Clearpoint Neuro Inc has a staff strength of 0 employees.

Stock update

Shares of Clearpoint Neuro Inc opened at $9.9 at the start of the last trading session i.e. 2022-11-02.

The stocks traded within a range of $9.59 - $10.02, and closed at $9.69.

This is a -1.92% slip from the previous day's closing price.

A total volume of 108,404 shares were traded at the close of the day’s session.

In the last one week, shares of Clearpoint Neuro Inc have slipped by -3.1%.

Clearpoint Neuro Inc's Key Ratios

Clearpoint Neuro Inc has a market cap of $0.237 billion, indicating a price to book ratio of 5.88 and a price to sales ratio of 12.43.

In the last 12-months Clearpoint Neuro Inc’s revenue was $0.019 billion with a gross profit of $0.011 billion and an EBITDA of $-0.016 billion. The EBITDA ratio measures Clearpoint Neuro Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Clearpoint Neuro Inc’s operating margin was -83.1% while its return on assets stood at -14.9% with a return of equity of -36.1%.

In Q2, Clearpoint Neuro Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 52.4%.

Clearpoint Neuro Inc’s PE and PEG Ratio

Forward PE
-
Trailing PE
-
PEG
None

Its diluted EPS in the last 12-months stands at $-0.722 per share while it has a forward price to earnings multiple of - and a PEG multiple of None. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Clearpoint Neuro Inc’s profitability.

Clearpoint Neuro Inc stock is trading at a EV to sales ratio of 11.46 and a EV to EBITDA ratio of -14.1. Its price to sales ratio in the trailing 12-months stood at 12.43.

Clearpoint Neuro Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$0.000 billion
Total Liabilities
$0.000 billion
Operating Cash Flow
$0.000 billion
Capital Expenditure
$0.000 billion
Dividend Payout Ratio
0%

Clearpoint Neuro Inc ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.

Clearpoint Neuro Inc ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.

Clearpoint Neuro Inc’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.

In 1970, Clearpoint Neuro Inc's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.

Comparatively, Clearpoint Neuro Inc paid $0 billion in dividends in 1970.

Other key metrics

Current Trading Price
$9.69
52-Week High
$19.5
52-Week Low
$7
Analyst Target Price
$20.25

Clearpoint Neuro Inc stock is currently trading at $9.69 per share. It touched a 52-week high of $19.5 and a 52-week low of $19.5. Analysts tracking the stock have a 12-month average target price of $20.25.

Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.

Frequently Asked Questions About Clearpoint Neuro Inc

The stock symbol (also called stock or share ticker) of Clearpoint Neuro Inc is CLPT

The IPO of Clearpoint Neuro Inc took place on 2020-02-12

Similar Industry Stocks (SURGICAL & MEDICAL INSTRUMENTS & APPARATUS)

Last Price
Chg
Chg%
Pro-Dex Inc (PDEX)
$18.8
-0.08
-0.42%
$73.53
-1.73
-2.3%
$0.42
0
+0.33%
$211.97
-8.12
-3.69%
$43.12
-1.01
-2.29%

Most Active

Last Price
Chg
Chg%
$58.63
-1.03
-1.73%
$92.12
-4.67
-4.82%
$5.12
-0.61
-10.65%
Apple Inc (AAPL)
$145.03
-5.62
-3.73%
$0.06
0.01
+12.74%

Top Gainers

Last Price
Chg
Chg%
$73
42.7
+140.92%
Oi S.A (OIBR-C)
$0
0
+100%
$0.02
0.01
+100%
$0.25
0.1
+66.44%
$2.85
1.01
+54.86%

Top Losers

Last Price
Chg
Chg%
$5.36
-22.58
-80.82%
$0.02
-0.06
-78.67%
Air T, Inc (AIRTW)
$0.01
-0.03
-75%
$4.51
-5.17
-53.41%
$11.5
-12.2
-51.48%

About

ClearPoint Neuro, Inc. is a medical device company primarily in the United States. The company is headquartered in Irvine, California.

Address

5 MUSICK, IRVINE, CA, US